Arvinas and Pfizer complete Rigel license deal for vepdegestrant
Go back to Arvinas and Pfizer complete Rigel license deal for vepdegestrant| (NASDAQ: ARVN) | Delayed: 8.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.26 | 52 Week High | $ | |||
| Open | $8.21 | 52 Week Low | $ | |||
| Day High | $8.40 | P/E | N/A | |||
| Day Low | $8.15 | EPS | $ | |||
| Volume | 642,473 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.82 -0.12 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.94 | 52 Week High | $37.39 | |||
| Open | $25.18 | 52 Week Low | $28.25 | |||
| Day High | $25.19 | P/E | 15.04 | |||
| Day Low | $24.78 | EPS | $1.65 | |||
| Volume | 32,977,136 | |||||

